Table 1 Characteristics of the patients at baseline.
From: Intercostal approach VATS is feasible for large-sized anterior mediastinal tumors
Variables | Group A (n = 61) | Group B (n = 68) | P value |
|---|---|---|---|
Age (years, mean ± SD) | 52.31 ± 13.76 | 51.85 ± 16.08 | 0.132 |
BMI (kg/m2, mean ± SD) | 24.39 ± 3.22 | 23.33 ± 3.13 | 0.772 |
Sex, n (%) | 0.735 | ||
Male | 35 (57.38) | 37 (54.44) | |
Female | 26 (42.62) | 31 (45.56) | |
Smoking status, n (%) | 0.138 | ||
Never | 55 (90.16) | 55 (80.88) | |
Ever | 6 (9.84) | 13 (19.12) | |
Drinking status, n (%) | 0.442 | ||
Never | 54 (88.52) | 57 (83.82) | |
Ever | 7 (11.48) | 11 (16.18) | |
Comorbidity, n (%) | |||
Hypertension | 10 (16.39) | 17 (25.00) | 0.230 |
Diabetes mellitus | 4 (6.55) | 2 (2.94) | 0.421 |
ASA status class, n (%) | 0.157 | ||
I | 44 (72.13) | 41 (60.29) | |
II | 17 (27.87) | 27 (39.71) | |
Tumor diameter (cm), mean ± SD (range) | 2.88 ± 0.90 (1.0–5.0) | 6.96 ± 2.61 (5.0–10.0) | < 0.001 |
Pathology | 0.728 | ||
Thymic carcinoma, n (%) | 3 (4.92) | 5 (7.35) | |
Type A thymic tumor, n (%) | 4 (6.56) | 10 (14.71) | |
Type B1 thymic tumor, n (%) | 3 (4.92) | 4 (5.88) | |
Type B2 thymic tumor, n (%) | 3 (4.92) | 1 (1.47) | |
Type B3 thymic tumor, n (%) | 3 (4.92) | 1 (1.47) | |
Type AB thymic tumor, n (%) | 14 (22.95) | 12 (17.65) | |
Thymic hyperplasia, n (%) | 6 (9.84) | 5 (7.35) | |
Thymic cyst, n (%) | 18 (29.51) | 22 (32.35) | |
Teratoma, n (%) | 7 (11.48) | 8 (11.76) |
